Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease

scientific article published on 07 May 2013

Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/1354750X.2013.790074
P698PubMed publication ID23651343

P2093author name stringYing Ji
Lin-Lin Ma
Ru-Juan Xie
Shi-Ping Na
Yu-Shi Bao
Shi-Lei Zhao
P2860cites workPrevention of allogeneic fetal rejection by tryptophan catabolismQ24336018
IDO expression by dendritic cells: tolerance and tryptophan catabolismQ29614752
Inhibition of experimental asthma by indoleamine 2,3-dioxygenaseQ35835456
P433issue5
P921main subjectchronic renal insufficiencyQ736715
P304page(s)379-385
P577publication date2013-05-07
P1433published inBiomarkersQ4915076
P1476titleSerum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease
P478volume18

Reverse relations

cites work (P2860)
Q87078670Bone Marrow Mesenchymal Stem Cells Alleviate Extracellular Kynurenine Levels, as Detected by High-Performance Liquid Chromatography
Q53702610Calcineurin inhibitors and nephrotoxicity in children.
Q101574185Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics
Q64096260Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
Q60919356Unique roles of tryptophanyl-tRNA synthetase in immune control and its therapeutic implications

Search more.